Literature DB >> 1999837

An investigation of ring and dicentric chromosomes found in three Turner's syndrome patients using DNA analysis and in situ hybridisation with X and Y chromosome specific probes.

C Cooper1, J A Crolla, C Laister, D I Johnston, P Cooke.   

Abstract

We have studied three patients with features of Turner's syndrome, two with a 45,X/46,X,r(?) and the third with a 45,X/46,X,dic?(Y) karyotype. Because Turner's syndrome patients with a mosaic karyotype containing a Y chromosome are known to have a high risk of developing gonadal tumours, we used DNA analysis and in situ hybridisation with X and Y specific probes to identify the chromosomal origin of the rings and dicentric chromosomes in the three index patients. Both ring chromosomes were shown to be of X origin, while the dicentric was composed of Y chromosome material. We discuss the importance of using a combination of molecular and cytogenetic analyses in such cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999837      PMCID: PMC1016740          DOI: 10.1136/jmg.28.1.6

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

Review 1.  The relationship of neoplasia to disorders of abnormal sexual differentiation.

Authors:  J L Simpson; G Photopulos
Journal:  Birth Defects Orig Artic Ser       Date:  1976

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  A simple technique for demonstrating centromeric heterochromatin.

Authors:  A T Sumner
Journal:  Exp Cell Res       Date:  1972-11       Impact factor: 3.905

Review 5.  Gonadoblastoma. A review of 74 cases.

Authors:  R E Scully
Journal:  Cancer       Date:  1970-06       Impact factor: 6.860

6.  A mosaic 45,X/46,X,r(?) karyotype investigated with X and Y centromere-specific probes using a non-autoradiographic in situ hybridization technique.

Authors:  J A Crolla; J C Llerena
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

7.  Nonfluorescent Y chromosomes. Cytologic evidence of origin.

Authors:  E Magenis; T Donlon
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  The age of occurrence of gonadal tumors in intersex patients with a Y chromosome.

Authors:  M Manuel; P K Katayama; H W Jones
Journal:  Am J Obstet Gynecol       Date:  1976-02-01       Impact factor: 8.661

9.  Properties of fetal and adult red blood cell arginase: a possible prenatal diagnostic test for arginase deficiency.

Authors:  E B Spector; M Kiernan; B Bernard; S D Cederbaum
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

10.  Cosmid clones derived from both euchromatic and heterochromatic regions of the human Y chromosome.

Authors:  J Wolfe; R P Erickson; P W Rigby; P N Goodfellow
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  3 in total

Review 1.  Small marker X chromosomes lack the X inactivation center: implications for karyotype/phenotype correlations.

Authors:  D J Wolff; C J Brown; S Schwartz; A M Duncan; U Surti; H F Willard
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

2.  A non-isotopic in situ hybridisation study of the chromosomal origin of 15 supernumerary marker chromosomes in man.

Authors:  J A Crolla; N R Dennis; P A Jacobs
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

Review 3.  Isodicentric Y chromosome: cytogenetic, molecular and clinical studies and review of the literature.

Authors:  C M Tuck-Muller; H Chen; J E Martínez; C C Shen; S Li; C Kusyk; D A Batista; Y M Bhatnagar; E Dowling; W Wertelecki
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.